Expression of the SLAM family of receptors adapter EAT-2 as a novel strategy for enhancing beneficial immune responses to vaccine antigens

Journal of Immunology

Volumn 186, Issue 2, 2011, Pages 722-732

  Aldhamen, Yasser A ^a   Appledorn, Daniel M ^a   Seregin, Sergey S ^a   Liu, Chyong Jy J ^a   Schuldt, Nathaniel J ^a   Godbehere, Sarah ^a   Amalfitano, Andrea ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM IONOPHORE; CD4 ANTIGEN; CD8 ANTIGEN; CD8ALPHA ANTIGEN; CD8BETA ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 21; INTERLEUKIN 22; JANUS KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; RECOMBINANT INTERLEUKIN 21; STAT3 PROTEIN; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL LINEAGE; CELL MATURATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG ACTIVITY; ENZYME ACTIVATION; EXON; GENE INDUCTION; GENE SEQUENCE; GENE STRUCTURE; HELPER CELL; HUMAN; IMMUNOSTIMULATION; INTRON; LEUKOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAINBOW TROUT; TH1 CELL; TH17 CELL; TH2 CELL;

ADENOVIRIDAE INFECTIONS; ADENOVIRUSES, HUMAN; AIDS VACCINES; ANIMALS; CELL LINE; CELLS, CULTURED; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; GENETIC ENGINEERING; GENETIC VECTORS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MULTIGENE FAMILY; TRANSCRIPTION FACTORS;

EID: 79251583161     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002105     Document Type: Article

References (54)

1. Rerks-Ngarm, S., P. Pitisuttithum, S. Nitayaphan, J. Kaewkungwal, J. Chiu, R. Paris, N. Premsri, C. Namwat, M. de Souza, and E. Adams, et al. 2009. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand. N. Engl. J. Med. 361: 2209-2220.
2. Buchbinder, S. P., D. V. Mehrotra, A. Duerr, D. W. Fitzgerald, R. Mogg, D. Li, P. B. Gilbert, J. R. Lama, M. Marmor, C. Del Rio, et al; Step Study Protocol Team. 2008. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372: 1881-1893.
3. McElrath, M. J., S. C. De Rosa, Z. Moodie, S. Dubey, L. Kierstead, H. Janes, O. D. Defawe, D. K. Carter, J. Hural, R. Akondy, et al; Step Study Protocol Team. 2008. HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis. Lancet 372: 1894-1905.
4. Kool, M., V. Pétrilli, T. De Smedt, A. Rolaz, H. Hammad, M. van Nimwegen, I. M. Bergen, R. Castillo, B. N. Lambrecht, and J. Tschopp. 2008. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J. Immunol. 181: 3755-3759.
5. Mbow, M. L., E. De Gregorio, N. M. Valiante, and R. Rappuoli. 2010. New adjuvants for human vaccines. Curr. Opin. Immunol. 22: 411-416.
6. Wille-Reece, U., B. J. Flynn, K. Loré, R. A. Koup, R. M. Kedl, J. J. Mattapallil, W. R. Weiss, M. Roederer, and R. A. Seder. 2005. HIV Gag protein conjugated to a Toll-like receptor 7/8 agonist improves the magnitude and quality of Th1 and CD8+ T cell responses in nonhuman primates. Proc. Natl. Acad. Sci. USA 102: 15190-15194.
7. Iwasaki, A., and R. Medzhitov. 2004. Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 5: 987-995.
8. Pulendran, B., and R. Ahmed. 2006. Translating innate immunity into immunological memory: implications for vaccine development. Cell 124: 849-863.
9. Appledorn, D. M., Y. A. Aldhamen, W. Depas, S. S. Seregin, C. J. Liu, N. Schuldt, D. Quach, D. Quiroga, S. Godbehere, I. Zlatkin, et al. 2010. A new adenovirus based vaccine vector expressing an Eimeria tenella derived TLR agonist improves cellular immune responses to an antigenic target. PLoS ONE 5: e9579.
10. Hartman, Z. C., T. Osada, O. Glass, X. Y. Yang, G. J. Lei, H. K. Lyerly, and T. M. Clay. 2010. Ligand-independent toll-like receptor signals generated by ectopic overexpression of MyD88 generate local and systemic antitumor immunity. Cancer Res. 70: 7209-7220.
11. Veillette, A., Z. Dong, L. A. Pérez-Quintero, M. C. Zhong, and M. E. Cruz-Munoz. 2009. Importance and mechanism of 'switch' function of SAP family adapters. Immunol. Rev. 232: 229-239.
12. Veillette, A. 2006. Immune regulation by SLAM family receptors and SAP-related adaptors. Nat. Rev. Immunol. 6: 56-66.
13. Veillette, A., Z. Dong, and S. Latour. 2007. Consequence of the SLAM-SAP signaling pathway in innate-like and conventional lymphocytes. Immunity 27: 698-710.
14. Flaig, R. M., S. Stark, and C. Watzl. 2004. Cutting edge: NTB-A activates NK cells via homophilic interaction. J. Immunol. 172: 6524-6527.
15. Ma, C. S., K. E. Nichols, and S. G. Tangye. 2007. Regulation of cellular and humoral immune responses by the SLAM and SAP families of molecules. Annu. Rev. Immunol. 25: 337-379.
16. Calpe, S., N. Wang, X. Romero, S. B. Berger, A. Lanyi, P. Engel, and C. Terhorst. 2008. The SLAM and SAP gene families control innate and adaptive immune responses. Adv. Immunol. 97: 177-250.
17. Veillette, A. 2006. NK cell regulation by SLAM family receptors and SAP-related adapters. Immunol. Rev. 214: 22-34.
18. Bleharski, J. R., K. R. Niazi, P. A. Sieling, G. Cheng, and R. L. Modlin. 2001. Signaling lymphocytic activation molecule is expressed on CD40 ligand-activated dendritic cells and directly augments production of inflammatory cytokines. J. Immunol. 167: 3174-3181.
19. Wang, N., A. Satoskar, W. Faubion, D. Howie, S. Okamoto, S. Feske, C. Gullo, K. Clarke, M. R. Sosa, A. H. Sharpe, and C. Terhorst. 2004. The cell surface receptor SLAM controls T cell and macrophage functions. J. Exp. Med. 199: 1255-1264.
20. Takeshita, F., T. Tanaka, T. Matsuda, M. Tozuka, K. Kobiyama, S. Saha, K. Matsui, K. J. Ishii, C. Coban, S. Akira, et al. 2006. Toll-like receptor adaptor molecules enhance DNA-raised adaptive immune responses against influenza and tumors through activation of innate immunity. J. Virol. 80: 6218-6224.
21. Hartman, Z. C., A. Kiang, R. S. Everett, D. Serra, X. Y. Yang, T. M. Clay, and A. Amalfitano. 2007. Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. J. Virol. 81: 1796-1812.
22. Appledorn, D. M., A. McBride, S. Seregin, J. M. Scott, N. Schuldt, A. Kiang, S. Godbehere, and A. Amalfitano. 2008. Complex interactions with several arms of the complement system dictate innate and humoral immunity to adenoviral vectors. Gene Ther. 15: 1606-1617.
23. He, T. C., S. Zhou, L. T. da Costa, J. Yu, K. W. Kinzler, and B. Vogelstein. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. USA 95: 2509-2514.
24. Ng, P., and F. L. Graham. 2002. Construction of first-generation adenoviral vectors. Methods Mol. Med. 69: 389-414.
25. Appledorn, D. M., S. Patial, A. McBride, S. Godbehere, N. Van Rooijen, N. Parameswaran, and A. Amalfitano. 2008. Adenovirus vector-induced innate inflammatory mediators, MAPK signaling, as well as adaptive immune responses are dependent upon both TLR2 and TLR9 in vivo. J. Immunol. 181: 2134-2144.
26. Perfetto, S. P., P. K. Chattopadhyay, L. Lamoreaux, R. Nguyen, D. Ambrozak, R. A. Koup, and M. Roederer. 2006. Amine reactive dyes: an effective tool to discriminate live and dead cells in polychromatic flow cytometry. J. Immunol. Methods 313: 199-208.
27. Seregin, S. S., Y. A. Aldhamen, D. M. Appledorn, N. J. Schuldt, A. J. McBride, M. Bujold, S. S. Godbehere, and A. Amalfitano. 2009. CR1/2 is an important suppressor of adenovirus-induced innate immune responses and is required for induction of neutralizing antibodies. Gene Ther. 16: 1245-1259.
28. Seregin, S. S., D. M. Appledorn, A. J. McBride, N. J. Schuldt, Y. A. Aldhamen, T. Voss, J. Wei, M. Bujold, W. Nance, S. Godbehere, and A. Amalfitano. 2009. Transient pretreatment with glucocorticoid ablates innate toxicity of systemically delivered adenoviral vectors without reducing efficacy. Mol. Ther. 17: 685-696.
29. Lindsay, R. W., P. A. Darrah, K. M. Quinn, U. Wille-Reece, L. M. Mattei, A. Iwasaki, S. P. Kasturi, B. Pulendran, J. G. Gall, A. G. Spies, and R. A. Seder. 2010. CD8+ T cell responses following replication-defective adenovirus serotype 5 immunization are dependent on CD11c+ dendritic cells but show redundancy in their requirement of TLR and nucleotide-binding oligomerization domain-like receptor signaling. J. Immunol. 185: 1513-1521.
30. Zhu, J., X. Huang, and Y. Yang. 2008. A critical role for type I IFN-dependent NK cell activation in innate immune elimination of adenoviral vectors in vivo. Mol. Ther. 16: 1300-1307.
31. Muruve, D. A. 2004. The innate immune response to adenovirus vectors. Hum. Gene Ther. 15: 1157-1166.
32. Gonzalez-Aseguinolaza, G., L. Van Kaer, C. C. Bergmann, J. M. Wilson, J. Schmieg, M. Kronenberg, T. Nakayama, M. Taniguchi, Y. Koezuka, and M. Tsuji. 2002. Natural killer T cell ligand alpha-galactosylceramide enhances protective immunity induced by malaria vaccines. J. Exp. Med. 195: 617-624.
33. Wille-Reece, U., B. J. Flynn, K. Loré, R. A. Koup, A. P. Miles, A. Saul, R. M. Kedl, J. J. Mattapallil, W. R. Weiss, M. Roederer, and R. A. Seder. 2006. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J. Exp. Med. 203: 1249-1258.
34. Darrah, P. A., D. T. Patel, P. M. De Luca, R.W. Lindsay, D. F. Davey, B. J. Flynn, S. T. Hoff, P. Andersen, S. G. Reed, S. L. Morris, et al. 2007. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat. Med. 13: 843-850.
35. Betts, M. R., M. C. Nason, S. M. West, S. C. De Rosa, S. A. Migueles, J. Abraham, M. M. Lederman, J. M. Benito, P. A. Goepfert, M. Connors, et al. 2006. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107: 4781-4789.
36. Yang, Y., C. T. Huang, X. Huang, and D. M. Pardoll. 2004. Persistent Toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat. Immunol. 5: 508-515.
37. Vitale, M., M. Della Chiesa, S. Carlomagno, D. Pende, M. Aricò, L. Moretta, and A. Moretta. 2005. NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106: 566-571.
38. Mailliard, R. B., Y. I. Son, R. Redlinger, P. T. Coates, A. Giermasz, P. A. Morel, W. J. Storkus, and P. Kalinski. 2003. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J. Immunol. 171: 2366-2373.
39. Piccioli, D., S. Sbrana, E. Melandri, and N. M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195: 335-341.
40. Martín-Fontecha, A., L. L. Thomsen, S. Brett, C. Gerard, M. Lipp, A. Lanzavecchia, and F. Sallusto. 2004. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat. Immunol. 5: 1260-1265.
41. Kelly, J. M., P. K. Darcy, J. L. Markby, D. I. Godfrey, K. Takeda, H. Yagita, and M. J. Smyth. 2002. Induction of tumor-specific T cell memory by NK cell-mediated tumor rejection. Nat. Immunol. 3: 83-90.
42. Krebs, P., M. J. Barnes, K. Lampe, K. Whitley, K. S. Bahjat, B. Beutler, E. Janssen, and K. Hoebe. 2009. NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses. Blood 113: 6593-6602.
43. Cruz-Munoz, M. E., Z. Dong, X. Shi, S. Zhang, and A. Veillette. 2009. Influence of CRACC, a SLAM family receptor coupled to the adaptor EAT-2, on natural killer cell function. Nat. Immunol. 10: 297-305.
44. Tassi, I., and M. Colonna. 2005. The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase Cgamma signaling pathways in human NK cells. J. Immunol. 175: 7996-8002. (Pubitemid 41798361)
45. Eissmann, P., and C. Watzl. 2006. Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells. J. Immunol. 177: 3170-3177. (Pubitemid 44277835)
46. Fujii, S., K. Shimizu, C. Smith, L. Bonifaz, and R. M. Steinman. 2003. Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J. Exp. Med. 198: 267-279.
47. Hermans, I. F., J. D. Silk, U. Gileadi, M. Salio, B. Mathew, G. Ritter, R. Schmidt, A. L. Harris, L. Old, and V. Cerundolo. 2003. NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J. Immunol. 171: 5140-5147.
48. Cerundolo, V., J. D. Silk, S. H. Masri, and M. Salio. 2009. Harnessing invariant NKT cells in vaccination strategies. Nat. Rev. Immunol. 9: 28-38.
49. Hermans, I. F., J. D. Silk, U. Gileadi, S. H. Masri, D. Shepherd, K. J. Farrand, M. Salio, and V. Cerundolo. 2007. Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells. J. Immunol. 178: 2721-2729.
50. Dondji, B., E. Deak, K. Goldsmith-Pestana, E. Perez-Jimenez, M. Esteban, S. Miyake, T. Yamamura, and D. McMahon-Pratt. 2008. Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection against Leishmania. Eur. J. Immunol. 38: 706-719.
51. Ostrakhovitch, E. A., Y. Wang, and S. S. Li. 2009. SAP binds to CD22 and regulates B cell inhibitory signaling and calcium flux. Cell. Signal. 21: 540-550.
52. Li, C., B. Chung, J. Tao, C. Iosef, A. Aoukaty, Y. Wang, R. Tan, and S. S. Li. 2008. The X-linked lymphoproliferative syndrome gene product SAP regulates B cell function through the FcgammaRIIB receptor. Cell. Signal. 20: 1960-1967.
53. Liu, J., K. L. O'Brien, D. M. Lynch, N. L. Simmons, A. La Porte, A. M. Riggs, P. Abbink, R. T. Coffey, L. E. Grandpre, M. S. Seaman, et al. 2009. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 457: 87-91.
54. Kong, W. P., L. Wu, T. C. Wallstrom, W. Fischer, Z. Y. Yang, S. Y. Ko, N. L. Letvin, B. F. Haynes, B. H. Hahn, B. Korber, and G. J. Nabel. 2009. Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination. J. Virol. 83: 2201-2215.